Through the help of Dr. Katinka van der Merwe at The Spero Clinic, Emma was able to get her life back from CRPS.

The combined net Q1 2025 revenue of approximately $2.2 million for prescription and non-prescription products, including license revenue, decreased approximately 6% versus net Q1 2024 revenue of $2.4 million and 37% versus net Q4 2024 revenue of $3.5 million 

Mytesi prescription volume increased by approximately 1.8% in Q1 2025 over Q1 2024 and decreased by approximately 13.5% in Q1 2025 over Q4 2024

Proprietary AI Tools Behind Millions of Cases Help Accelerate Digital Dentistry Workflows

Television App Delivers Accessible Dental Video Content for Champions of Quality Healthcare

Compression Distraction Technology Enhances Mission of Improving the Quality of Life for Foot and Ankle Patients

With the successful completion of its latest Joint Commission Accreditation survey, the Florida-based behavioral health facility reinforces its commitment to quality and safety

Alter Behavioral Health Launches Crisis-Focused Residential Mental Health Facility in Capo Beach, Orange County, California

Top-to-Top Conversation Offers Transparency and Confidence

Ahead of Q1 Earnings Report

9 of 10 frontline AML patients achieve remission with mipletamig + standard of care across two trials

Mipletamig triplet combination continues to outperform standard doublet benchmark

No cytokine release syndrome observed in the ongoing RAINIER trial: favorable safety profile supports role in frontline AML

Cohort 2 enrollment is complete, and Cohort 3 is now enrolling

Antimicrobial resistance is recognized as one of the top global public health threats, and Telomir-Ag2 strengthens Telomir's pipeline with a differentiated candidate designed to address this urgent and expanding crisis

Retired Navy Captain and Presidential Physician Brings Unparalleled Expertise to Leading Telemedicine Platform

With Zepbound at Its Core, The Naderi Center's New Initiative Addresses Male Weight Loss and Facial Rejuvenation Through Physician-Led, Individualized Care

Leading life science executives, government officials, academic leaders, and investors gather for two day off-the-record networking and discussion forum

69% Blame Poor EHR Usability for Job Dissatisfaction, 80% Consider Nurse-Friendly Systems When Job Hunting, and 2 in 3 Nurses Under 40 Say EHR Experience Impacts Employer Choice - Black Book's Sweeping 8-Month Survey Finds

Neurotrack's screening platform helped to increase the rate of dementia detection by 29% in four months

Collaboration unites SumHealth's healthcare industry expertise and BenchMarks analytics tool with Gigasheet's powerful data processing platform to deliver unprecedented access to hospital and payer real-world healthcare prices.

Crackable chocolatey shell. Grass-fed A2/A2 dairy ice cream. Over a billion probiotics plus prebiotics. 10g of sugar 160 cal or less.

- Dermata announced positive topline results from its XYNGARI™ Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial, achieving all co-primary endpoints -

- Dermata entered into a Clinical Trial Collaboration Agreement with Revance Therapeutics to study DMT410 with DAXXIFY® for the treatment of axillary hyperhidrosis -

- Raised $8.8 million in gross proceeds from private placement and warrant inducement financings during the first quarter of 2025 -

Company also expects to provide Q1 performance update pro forma for the pending acquisitions of Sportstech and Wattbike

This New Optimized STREAMLINE® Surgical System Features a Clear Tip for Enhanced Surgical Visibility

412% revenue growth reflects AI Nose sales in elderly care

Expanding AI-driven scent tech beyond healthcare into robotics and industrial applications

Exciting Updates for Company's Muscle Test Dynamometer to Offer Healthcare Professionals a More Powerful Tool to Assess Muscle Strength

NanoViricides Explains Its Drug Strategy for Combating Viral Infections and Pandemics

Expanding Beyond Gummies, Gummi World Launches Capsule Manufacturing to Deliver Full-Spectrum, Clinically Backed Supplement Solutions - Faster, Cleaner and All Under One Roof

Record Revenue Highlighted by 70% Growth in Single-Use Navigation and Therapy Products

Receives U.S. Patent for Groundbreaking Treatment for Opioid Use Disorder

Clinical Trial on Novel Analgesic, PF614-MPAR, Demonstrates Overdose Protection

Podiatrists offer evidence-based tips to help runners prevent foot pain and injuries.

The recognition honors Novak's leadership in clinical partnerships and his profound impact on adolescent mental health care

The innovative GeneSwift reagent kit from Gator Bio, along with GFP, CMV, and SV40 reagents, are designed to maintain the high-precision expected from ddPCR methods, while streamlining the genome titer workflow and accelerating results.

Research from Vibrant Sciences, confirming high sensitivity and broad pathogen coverage using low-volume antibody testing, published in Nature

As the world's nurses celebrate International Nurses Day (IND), the International Council of Nurses issues a rallying cry to governments around the globe for urgent nursing support, following the launch of the second World Health Organization (WHO) State of the World's Nursing (SOWN) report.

Seasoned operations executive brings proven track record in business transformation, strategic planning as company enters new growth phase

Experienced Medtech Executive to Lead EDGe Surgical Through Commercial Scale-Up and Product Line Expansion

Genomate Health, a leading precision oncology company, today announced its formal entry into the U.S. market during the SelectUSA Investment Summit, the premier event for international companies scaling into the United States.

~ Advanced Preparation for New Drug Application ~

Q1 revenues increased 412% year over year, driven by AI Nose products

Delivers strong turnaround from gross loss to gross profit in Q1

AI Nose gains traction beyond healthcare with strategic partnerships in robotics and semiconductor sectors

VELDONA® program advances with TFDA and IRB Approvals for two clinical trials in Taiwan

- Vikas Goyal, MBA, promoted to Partner to lead growth stage investments in late preclinical and clinical stage biotechnology companies.